Document is current
Any future updates will be listed below
-
Authors
Wang, Xiaowen
Hegde, Sheila M.
- License Information
-
More Information
Article History
First Online: 20 June 2024
Declarations
:
: Dr. Wang received funding from the ACC/Merck Research Fellowship, and reports individual stock options in Pfizer and Gilead Sciences and fees paid to the institution for core lab services from Bristol Meyers Squibb and Cytokinetics. Dr. Hegde reports fees paid to the institution for core lab services from Bristol Meyers Squibb and Cytokinetics.
Free to read: This content has been made available to all.
